5IGZ
Macrolide 2'-phosphotransferase type II - complex with GDP and spiramycin
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | CLSI BEAMLINE 08ID-1 |
Synchrotron site | CLSI |
Beamline | 08ID-1 |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2011-02-23 |
Detector | RAYONIX MX-300 |
Wavelength(s) | 0.9793 |
Spacegroup name | P 21 21 21 |
Unit cell lengths | 55.240, 72.430, 77.080 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 44.900 - 1.600 |
R-factor | 0.1623 |
Rwork | 0.161 |
R-free | 0.19520 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 5igv |
RMSD bond length | 0.019 |
RMSD bond angle | 1.479 |
Data reduction software | XDS |
Data scaling software | XSCALE |
Phasing software | PHENIX |
Refinement software | PHENIX (1.7.1_743) |
Data quality characteristics
Overall | Inner shell | Outer shell | |
Low resolution limit [Å] | 44.900 | 1.640 | |
High resolution limit [Å] | 1.600 | 7.160 | 1.600 |
Rmerge | 0.049 | 0.020 | 0.675 |
Number of reflections | 41503 | ||
<I/σ(I)> | 23.59 | 66.49 | 3.03 |
Completeness [%] | 100.0 | 99.3 | 100 |
Redundancy | 8.1 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION | 7.5 | 295 | 0.1 M calcium acetate, 0.1M Tris, 25-40% PEG 4000 |